The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

Ambulatory blood pressure monitoring is a method of measuring blood pressure at regular intervals over a 24-hour period, typically using a portable device.

ABPM provides a more comprehensive assessment of blood pressure throughout daily activities and sleep, offering insights into variations that may not be detected in clinic settings.

ABPM is recommended for patients suspected of having white coat hypertension, masked hypertension, resistant hypertension, or fluctuating blood pressure patterns.

The patient wears a small cuff attached to a portable monitor that automatically inflates and records blood pressure at regular intervals, usually every 15-30 minutes during waking hours and less frequently during sleep.

Most patients find ABPM comfortable, as the device is lightweight and designed for minimal disruption to daily activities. The cuff may inflate periodically but does not cause pain.

Varicose veins are enlarged, twisted veins that typically appear in the legs. They occur when the valves in the veins fail to function properly, causing blood to pool and the veins to swell.